Prime Medicine, Inc.

Prime Medicine, Inc.

PRME
Prime Medicine, Inc.US flagNASDAQ Global Market
3.12
USD
+0.07
- -
563.53MMarket Cap

Income Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
5
- -
- -
- -
3
5
+ Sales & Services Revenue
5
- -
- -
- -
3
5
- Cost of Revenue
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
+ Other Operating Income
-5
- -
- -
- -
-3
-5
- Operating Expenses
6
84
117
191
205
213
+ Selling, General & Admin
3
14
30
43
50
52
+ Research & Development
3
71
87
148
155
161
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-1
-84
-117
-191
-202
-208
- Non-Operating (Income) Loss
1
81
6
7
-7
-7
+ Interest Expense, Net
- -
- -
- -
-3
-4
-4
+ Interest Expense
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
3
4
4
+ Other Non-Op (Income) Loss
1
81
6
10
-3
-3
Pretax Income
-2
-166
-123
-198
-196
-201
- Income Tax Expense (Benefit)
2
- -
-1
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-3
-165
-122
-198
-196
-201
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-3
-165
-122
-198
-196
-201
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-3
-165
-122
-198
-196
-201
- Preferred Dividends
- -
17
20
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-3
-183
-142
-198
-196
-201
EBIT
-1
-84
-117
-191
-202
-208
EBITDA
-1
-84
-114
-187
-196
-201
EBITDA Margin (%)
-17.06
- -
- -
- -
-6,581.93
-4,340
EBITA
-1
-84
-117
-191
-202
-208
Gross Margin (%)
100
- -
- -
- -
100
100
Operating Margin (%)
-17.89
- -
- -
- -
-6,787.36
-4,498.06
Profit Margin (%)
-65.45
- -
- -
- -
-6,566.61
-4,342.44
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
1
2
5
6
7
Basic Weighted Avg Shares
72
72
34
91
119
149
Basic EPS, GAAP
-0.05
-2.54
-4.19
-2.18
-1.65
-1.35
Basic EPS from Cont Ops
-0.05
-2.3
-3.59
-2.18
-1.65
-1.35
Diluted Weighted Avg Shares
72
72
34
91
119
149
Diluted EPS, GAAP
-0.05
-2.54
-4.19
-2.18
-1.65
-1.35
Diluted EPS from Cont Ops
-0.05
-2.3
-3.59
-2.18
-1.65
-1.35

Balance Sheet (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
53
271
297
143
212
181
+ Cash, Cash Equivalents & STI
53
270
294
122
190
178
+ Cash & Cash Equivalents
37
185
188
42
182
63
+ ST Investments
16
84
106
80
8
115
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
3
21
21
4
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
1
31
64
51
86
161
+ Property, Plant & Equip, Net
1
16
49
37
72
147
+ Property, Plant & Equip
1
16
51
44
85
167
- Accumulated Depreciation
- -
1
3
7
14
20
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
1
16
15
14
14
15
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
1
16
15
14
14
15
Total Assets
55
302
360
194
298
343
+ Payables & Accruals
- -
36
8
36
17
12
+ Accounts Payable
- -
1
4
20
11
9
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
35
4
17
6
4
+ ST Debt
- -
7
12
9
4
8
+ ST Borrowings
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
7
12
9
4
8
+ Other ST Liabilities
19
15
7
11
17
17
+ Deferred Revenue
- -
- -
- -
- -
7
8
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
19
15
7
11
10
9
Total Current Liabilities
19
58
27
56
38
37
+ LT Debt
- -
3
17
4
37
108
+ LT Borrowings
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
3
17
4
37
108
+ Other LT Liabilities
2
1
- -
- -
69
76
+ Accrued Liabilities
2
1
- -
- -
69
76
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
2
4
17
4
106
184
Total Liabilities
21
62
44
61
144
222
+ Preferred Equity and Hybrid Capital
31
396
- -
- -
- -
- -
+ Share Capital & APIC
8
15
610
624
840
1,009
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
8
15
610
624
840
1,009
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-6
-171
-293
-491
-687
-888
+ Other Equity
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
33
240
316
133
153
121
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
Total Equity
33
240
316
133
153
121
Total Liabilities & Equity
55
302
360
194
298
343
Shares Outstanding
94
97
97
97
131
181
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
10
29
14
41
116
Net Debt
-37
-185
-188
-42
-182
-63
Net Debt to Equity
-110.46
-77.4
-59.32
-31.24
-119.15
-52.15
Tangible Common Equity Ratio
4.27
-51.76
87.78
68.65
51.48
35.27
Current Ratio
2.75
4.67
11.1
2.53
5.58
4.84
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-3
-165
-122
-198
-196
-201
+ Depreciation & Amortization
- -
1
2
5
6
7
+ Non-Cash Items
-2
100
23
25
36
37
+ Stock-Based Compensation
- -
2
6
14
26
29
+ Deferred Income Taxes
2
-1
-1
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
-5
98
18
12
10
7
+ Chg in Non-Cash Work Cap
- -
31
-35
3
31
-5
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-2
-9
-16
5
+ Inc (Dec) in Accts Payable
1
36
-23
24
-17
- -
+ Inc (Dec) in Other
- -
-4
-10
-12
64
-10
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-6
-34
-132
-165
-123
-163
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-4
-16
-9
-7
-5
+ Acq of Fixed Prod Assets
-1
-4
-16
-9
-7
-5
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
185
- -
170
138
+ Increase in Capital Stock
- -
- -
185
- -
170
138
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
-69
-30
28
75
-104
+ Dec in LT Investment
- -
13
93
133
204
101
+ Inc in LT Investment
- -
-82
-123
-105
-129
-205
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
-1
- -
1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
-74
-47
19
68
-109
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
35
269
-4
1
26
13
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
35
269
181
1
196
152
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
28
162
3
-146
141
-120
EBITDA
-1
-84
-114
-187
-196
-201
EBITDA Margin (%)
-17.06
- -
- -
- -
-6,581.93
-4,340
Free Cash Flow
-6
-38
-148
-174
-130
-167
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
309
-564
-174
-130
-167
Free Cash Flow per Basic Share
-0.09
-0.53
-4.36
-1.91
-1.1
-1.12
Price/Free Cash Flow
- -
- -
-5.44
-5.14
-3
-3.27
Cash Flow to Net Income
1.63
0.21
1.08
0.83
0.63
0.81
Capital Expenditures
-1
-4
-16
-9
-7
-5